Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1 Introduction The fields of molecular diagnostics and targeted therapeutics are evolving rapidly, with numerous commercial and academic laboratories providing somatic and germline services on a variety of platforms. Molecular diagnostic studies utilizing next-generation sequencing (NGS) of tumor tissue are now fundamental for diagnosis, prognosis and treatment decision-making in cancer.
The evaluation and management of nausea in patients near the end of life can be more challenging than that of nausea in patients undergoing antineoplastic therapies. Unlike in the oncology setting in which nausea is primarily managed using antiemetic regimens that have been developed with the neuropharmacology and emetogenic potentials of chemotherapy agents in mind, many patients receiving end-of-life care have nausea of multifactorial etiology.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
